Surmodics(SRDX) - 2024 Q4 - Annual Results

EXHIBIT 99.1 Surmodics Reports Fourth Quarter and Fiscal Year 2024 Financial Results November 6, 2024 07:00 a.m. ET EDEN PRAIRIE, Minn. – Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its fourth quarter and fiscal year ended September 30, 2024. Fourth Quarter Fiscal 2024 Financial Summary • Total Revenue of $33.2 million, an increase of 19% year-over-year • Total Revenue excluding Sur ...